Publikationen

Castleman’s disease in the rheumatological practice

Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report

Activity of afatinib in patients with NSCLC harboring novel uncommon EGFR mutations with or without co-mutations: a case report

• EGFR, non small cell lung cancer (NSCLC), tyrosine kinase inhibitor (TKI)

Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis

Testing for deficient mismatch repair and microsatellite instability : A focused update

• Immun-Checkpoint-Inhibition, Immune checkpoint inhibitors, Immunhistochemie, immunohistochemistry

Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract

• Adenosquamöses Karzinom, Adenosquamous carcinoma, esophageal adenocarcinoma, gastric cancer, Immun-Checkpoint-Inhibition, Immune checkpoint inhibitors, Magenkarzinom, PD-L1

The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations

• hybrid capture-based next-generation sequencing (NGS), Osimertinib, Resistenz, Resistenzmutation